Literature DB >> 25912785

Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.

Josef Goldufsky1, Stephen J Wood1, Vijayakumar Jayaraman1, Omar Majdobeh1, Lin Chen2, Shanshan Qin3, Chunxiang Zhang3, Luisa A DiPietro2, Sasha H Shafikhani1,4,5.   

Abstract

Diabetic foot ulcers are responsible for more hospitalizations than any other complication of diabetes. Bacterial infection is recognized as an important factor associated with impaired healing in diabetic ulcers. Pseudomonas aeruginosa is the most frequently detected Gram-negative pathogen in diabetic ulcers. P. aeruginosa infection has been shown to impair healing in diabetic wounds in a manner that correlates with its ability to form biofilm. While the majority of infections in diabetic ulcers are biofilm associated, 33% of infections are nonbiofilm in nature. P. aeruginosa is the most prevalent Gram-negative pathogen in all diabetic wound types, which suggests that the deleterious impact of P. aeruginosa on healing in diabetic wounds goes beyond its ability to form biofilm and likely involves other factors. The Type III Secretion System (T3SS) virulence structure is required for the pathogenesis of all P. aeruginosa clinical isolates, suggesting that it may also play a role in the inhibition of wound repair in diabetic skin ulcers. We evaluated the role of T3SS in mediating P. aeruginosa-induced tissue damage in the wounds of diabetic mice. Our data demonstrate that P. aeruginosa establishes a robust and persistent infection in diabetic wounds independent of its ability to form biofilm and causes severe wound damage in a manner that primarily depends on its T3SS.
© 2015 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25912785      PMCID: PMC4690211          DOI: 10.1111/wrr.12310

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  37 in total

Review 1.  Impaired wound healing.

Authors:  Nathan B Menke; Kevin R Ward; Tarynn M Witten; Danail G Bonchev; Robert F Diegelmann
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

2.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

3.  Multiple bacterial species reside in chronic wounds: a longitudinal study.

Authors:  Kristine Gjødsbøl; Jens Jørgen Christensen; Tonny Karlsmark; Bo Jørgensen; Bjarke M Klein; Karen A Krogfelt
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

4.  Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps.

Authors:  Sasha H Shafikhani; Joanne Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

5.  The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.

Authors:  L Garrity-Ryan; S Shafikhani; P Balachandran; L Nguyen; J Oza; T Jakobsen; J Sargent; X Fang; S Cordwell; M A Matthay; J N Engel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 6.  ExoU is a potent intracellular phospholipase.

Authors:  Hiromi Sato; Dara W Frank
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

7.  Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers.

Authors:  Hanna Galkowska; Waldemar L Olszewsk; Urszula Wojewodzka; Joanna Mijal; Ewa Filipiuk
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

Review 8.  Wound healing: an overview of acute, fibrotic and delayed healing.

Authors:  Robert F Diegelmann; Melissa C Evans
Journal:  Front Biosci       Date:  2004-01-01

9.  Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.

Authors:  Grant S Schulert; Heather Feltman; Shira D P Rabin; Ciara G Martin; Scott E Battle; Jordi Rello; Alan R Hauser
Journal:  J Infect Dis       Date:  2003-11-21       Impact factor: 5.226

10.  Enhancement of wound healing by topical treatment with epidermal growth factor.

Authors:  G L Brown; L B Nanney; J Griffen; A B Cramer; J M Yancey; L J Curtsinger; L Holtzin; G S Schultz; M J Jurkiewicz; J B Lynch
Journal:  N Engl J Med       Date:  1989-07-13       Impact factor: 91.245

View more
  17 in total

1.  Perioperative high inspired oxygen fraction therapy reduces surgical site infection with Pseudomonas aeruginosa in rats.

Authors:  Jeffrey S Kroin; Jinyuan Li; Josef W Goldufsky; Kajal H Gupta; Masoomeh Moghtaderi; Asokumar Buvanendran; Sasha H Shafikhani
Journal:  J Med Microbiol       Date:  2016-06-14       Impact factor: 2.472

2.  Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.

Authors:  Hee Kyoung Kang; Chang Ho Seo; Tudor Luchian; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

3.  IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.

Authors:  Ruchi Roy; Janet Zayas; Mohamed F Mohamed; Anahita Aboonabi; Kaylee Delgado; Jennillee Wallace; Mohammad Bayat; Timothy M Kuzel; Jochen Reiser; Sasha H Shafikhani
Journal:  J Invest Dermatol       Date:  2021-09-10       Impact factor: 7.590

4.  Pathogenic shifts in endogenous microbiota impede tissue regeneration via distinct activation of TAK1/MKK/p38.

Authors:  Christopher P Arnold; M Shane Merryman; Aleishia Harris-Arnold; Sean A McKinney; Chris W Seidel; Sydney Loethen; Kylie N Proctor; Longhua Guo; Alejandro Sánchez Alvarado
Journal:  Elife       Date:  2016-07-21       Impact factor: 8.140

5.  Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity.

Authors:  Stephen J Wood; Josef W Goldufsky; Daniella Bello; Sara Masood; Sasha H Shafikhani
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

6.  High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study).

Authors:  Robert J Commons; Claire H Robinson; David Gawler; Joshua S Davis; Ric N Price
Journal:  Diabetes Res Clin Pract       Date:  2015-09-21       Impact factor: 5.602

7.  Overriding impaired FPR chemotaxis signaling in diabetic neutrophil stimulates infection control in murine diabetic wound.

Authors:  Ruchi Roy; Janet Zayas; Sunil K Singh; Kaylee Delgado; Stephen J Wood; Mohamed F Mohamed; Dulce M Frausto; Yasmeen A Albalawi; Thea P Price; Ricardo Estupinian; Eileena F Giurini; Timothy M Kuzel; Andrew Zloza; Jochen Reiser; Sasha H Shafikhani
Journal:  Elife       Date:  2022-02-03       Impact factor: 8.140

8.  Pseudomonas aeruginosa ExoT induces G1 cell cycle arrest in melanoma cells.

Authors:  Mohamed F Mohamed; Stephen J Wood; Ruchi Roy; Jochen Reiser; Timothy M Kuzel; Sasha H Shafikhani
Journal:  Cell Microbiol       Date:  2021-04-14       Impact factor: 4.115

Review 9.  Macrophage Related Chronic Inflammation in Non-Healing Wounds.

Authors:  Meirong Li; Qian Hou; Lingzhi Zhong; Yali Zhao; Xiaobing Fu
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.